← Back to Search

single-arm for Coronary Artery Disease

Phase 4
Waitlist Available
Led By Dipan Shah, M.D.
Research Sponsored by Dipan Shah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7 days
Awards & highlights

Study Summary

This study is designed to evaluate the feasibility and diagnostic performance of a novel rapid regadenoson stress CMR protocol for detecting of obstructive coronary artery disease.

Eligible Conditions
  • Coronary Artery Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Profile of sensitivity, specificity, and diagnostic accuracy of rapid regadenoson stress CMR.
Secondary outcome measures
Evaluate time for performance of rapid regadenoson stress CMR protocol.

Side effects data

From 2014 Phase 4 trial • 20 Patients • NCT00871260
45%
Dyspnea or difficulty with breath
35%
Palpitations
35%
Chest pressure or heaviness
25%
Flushing
10%
Dysgeusia immediately following aminophylline administration
100%
80%
60%
40%
20%
0%
Study treatment Arm
Healthy Patients

Trial Design

1Treatment groups
Experimental Treatment
Group I: single-armExperimental Treatment1 Intervention
Additional images collected during routine cardiac MRI (CMR) with diagnostic imaging agent, regadenoson.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Regadenoson
FDA approved

Find a Location

Who is running the clinical trial?

Dipan ShahLead Sponsor
3 Previous Clinical Trials
100,180 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
120 Patients Enrolled for Coronary Artery Disease
Astellas Pharma Global Development, Inc.Industry Sponsor
192 Previous Clinical Trials
121,036 Total Patients Enrolled
3 Trials studying Coronary Artery Disease
1,259 Patients Enrolled for Coronary Artery Disease
Dipan Shah, M.D.Principal InvestigatorThe Methodist Hospital Research Institute

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease
Dipan Shah 2011. "Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01446094.
All > Coronary Artery Disease > Cardiovascular
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top